Buparlisib : A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer
AZD-9574: Dihydroartemisinin inhibits colon cancer cell viability by inducing apoptosis through up-regulation of PPAR γexpression